NFKB1 and Hyperglycemia: In this study, when the cells were exposed to exenatide, a drug used in the treatment of Type 2 diabetes mellitus, the inhibition of the NF-κB signaling pathway was observed, reducing SR stress induced by hyperglycemia [162].